Biodexa Pharmaceuticals
Abingdon
About Biodexa Pharmaceuticals
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through strategic acquisitions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $111.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: lse:MTPH
- Website: biodexapharma.com
- Phone: +44 1235 841575
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biodexa-pharmaceuticals-51658 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.